What question did this study set out to answer?

To investigate the role of SLC25A39 in hepatocellular carcinoma, focusing on its epigenetic and immune implications.

SLC25A39 Upregulation Is Associated with DNA Methylation, Immune Cell Infiltration, and Poor Prognosis in Hepatocellular Carcinoma

View Full Paper

Ask AI

Bookmark

To investigate the role of SLC25A39 in hepatocellular carcinoma, focusing on its epigenetic and immune implications.
Utilized integrated multi-omics analysis including TCGA and ssGSEA.
Conducted functional assays with CCK-8 and Transwell methods.
Analyzed promoter hypermethylation at specific CpG sites.
Examined immune cell infiltration and checkpoint expression.
Confirmed SLC25A39 upregulation in hepatocellular carcinoma.
Established a link between SLC25A39 promoter hypermethylation and poor prognosis.
Demonstrated an association with an immunosuppressive tumor microenvironment.
Identified reduced cytotoxic cell infiltration and elevated immune checkpoint expression.

No takes yet. Share an insight, caveat, or question.

Integrated multi-omics approach reveals SLC25A39's role in poor prognosis and immune modulation in hepatocellular carcinoma.

Mo et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark